Biotech Catalyst Calendar

One dated edition per month: every industry-sponsored Phase 2 and Phase 3 trial whose primary completion falls in the next two months, grouped by phase and graded for how much the date is worth believing. Every forward-looking completion date in the registry is the sponsor's estimate, so the grade — built from whether enrolment has closed, how far the trial has got, whether the sponsor named a day or only a month, and when the record was last revised — is the product. Withdrawn and suspended trials are kept off the calendar and listed separately. No PDUFA dates, no tickers, no probability of success: the registry publishes none of those.